ReviewTherapeutics and clinical risk management2021

Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives.

Dwan-Ying Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.